Mutations of SHP-2 have been found in various human malignancies and altered SHP-2 signaling culminates in the development of gastric adenocarcinoma in genetically engineered mice [35], [36], indicating that SHP-2 is involved in the development of gastric cancer. Here, PTPN11 is linked to gastric cancer.